Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report

Area of Science:

• Orthopedic Oncology
• Skeletal Pathology
• Tumor Histopathology

Background:

• Dedifferentiated chondrosarcoma (DDCS) comprises about 10% of chondrosarcomas, carrying a poor 5-year survival rate of only 10%.
• Common dedifferentiated components include osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.
• Accurate diagnosis is crucial for appropriate treatment and improved patient outcomes.

Observation:

• A rare case of DDCS in a 19-year-old female is reported.
• Radiological imaging showed an expansive osteolytic lesion in the proximal humerus with irregular calcification and cortical breakthrough.
• Histological examination revealed a biphasic tumor with features of both low-grade chondrosarcoma and a giant cell-rich lesion.

Findings:

• The dedifferentiated component exhibited a histological resemblance to a giant cell tumor of bone.
• Pathological examination confirmed a biphasic tumor with abrupt transition between chondrosarcoma and giant cell-rich components.
• This presentation challenges conventional understanding of DDCS dedifferentiation patterns.

Implications:

• This case expands the spectrum of histological appearances in dedifferentiated chondrosarcoma.
• It underscores the importance of comprehensive histopathological evaluation for accurate diagnosis.
• Recognizing this rare variant may aid in earlier detection and tailored therapeutic strategies for patients with DDCS.